T2D is a progressive multifactorial metabolic disease, which is the result of metabolic imbalances, in particular abnormal insulin production, elevated insulin resistance, high glucagon secretion, and drop in viable β-cell content [34]. This evidence concerns the gene INS and metabolic disease.